Adenosine receptor activation ameliorates type 1 diabetes. - Wikidata - awgldk - TriplyDB

Adenosine receptor activation ameliorates type 1 diabetes.

Adenosine receptor activation ameliorates type 1 diabetes.

http://www.wikidata.org/entity/Q36427003

about

Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes Purinergic signalling and diabetes The role of adenosinergic pathway in human autoimmune diseases Adenosine A2B Receptor: From Cell Biology to Human Diseases The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases Metabolic insights from zebrafish genetics, physiology, and chemical biology The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death.A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.The A2b adenosine receptor modulates glucose homeostasis and obesity Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.A2b adenosine receptor regulates hyperlipidemia and atherosclerosis Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.CD39 and CD73 in immunity and inflammation.The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes.A2B adenosine receptor dampens hypoxia-induced vascular leak.Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation.Immunomodulation using agonists and antagonists: potential clinical applications.Targeting adenosine receptors in the development of cardiovascular therapeutics.Adenosine A1 modulators: a patent update (2008 to present).Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond.The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets.Adenosine signaling promotes regeneration of pancreatic β cells in vivo.Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy.Role of A3 adenosine receptor in diabetic neuropathy.The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.

P2860

Q24655020-16C06474-2686-4ABC-8AD0-9683E8DB034F Q26825668-69AD469E-8CFD-49D8-89CE-FD0D894465D7 Q26828574-2EDC8A04-B392-4CF1-9B1A-CE2F7C2BFD21 Q28069199-58704B6E-9682-4389-AB71-5CDF5B047273 Q28074665-EEEECB67-ED91-436F-8FD0-2278534D456D Q28080657-5D50718C-A717-420E-B790-540FB8CAE3BA Q28084257-0915DE0F-805B-43C8-92B3-F5624D8323C0 Q30409961-0CB48A92-C30A-4373-8AE9-FD831FD4EE53 Q30434114-93E9A548-C843-4AD1-B09E-2656F7E9D910 Q30450509-BE94D224-E3F5-40DB-A0B7-DAC65025BEFA Q33698976-FB5F0B64-BC83-4190-AB03-FB9453F4B40A Q34017174-4EDFF9F1-11D8-42CC-9E68-97BBC26D6D25 Q34122487-50F7ED97-9D40-4CA8-9097-768C427F4F21 Q34357938-80BB772B-95AB-4C5B-8F64-1C85F3CE26C4 Q34615473-22BFEB47-AEF9-4419-92E4-C0B565AC4179 Q34703746-364EE157-D3CD-4E13-BB7D-89A53B1A6C78 Q35694128-64CF778F-DD9D-4590-82F7-A4DA4521F25D Q36070216-3A62ED23-56DD-4826-AA2E-48C919A907EB Q36496998-B1BDAE4D-F6BB-4DFF-BB6F-419DD6BF3957 Q36879416-225D2ACD-18B7-4B13-B8C5-FC69D984E66E Q36906658-14F17577-8F53-4CA0-A3EF-10E052B9D96F Q37160327-E1B19C4C-A5E1-4EAE-B8F9-011FAC4C6A36 Q37333575-6C0A9B0E-F831-4450-978D-E38A53D97EAC Q37336475-DF07E92A-7450-468C-9F30-C850AE9EFCC9 Q37360635-E3DCE3E2-BBA9-4087-A58E-8A3246DE0006 Q37373697-FD78267B-F5D4-4169-8D57-5BB3616DA7E9 Q37564150-FC4B8966-5562-4429-A849-58DD62BD5074 Q37597064-12A87163-C751-4F7A-B5C8-68A3A1C1C773 Q37965728-27C516B2-881F-47AB-83D2-932463112589 Q37990558-AA659F95-1759-4C41-B9CE-2AC4E2C20F44 Q38109907-D5100796-3E58-4FBC-935D-F56ED9936806 Q38272552-628C1F54-FF05-4315-AF82-2343EFC876F4 Q40946206-F9EB708D-4244-41F4-925F-39474F9ED20E Q42182907-0ED74DD2-526C-4F2E-BC44-73DD1B277A2D Q42197940-B2A222E1-3057-4E7D-92C8-6EBF2474C2AD Q47128638-CA5084E6-63DB-4F9E-AA5F-5CB1B18DF1B9 Q48732639-811882BF-65C5-49B1-BDAE-91CD530E2231 Q51695247-6639C48D-6BAF-42CF-8BB9-152C5C92357F Q55261560-9C44AB5B-8DAF-4488-B27C-0F0062E37CB6 Q55381414-BFFB173F-C10C-4B0F-BDC6-74BC27C96C6F

P2860

Adenosine receptor activation ameliorates type 1 diabetes.

http://www.wikidata.org/entity/Q36427003

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Adenosine receptor activation ameliorates type 1 diabetes.

@ast

Adenosine receptor activation ameliorates type 1 diabetes.

@en

type

label

Adenosine receptor activation ameliorates type 1 diabetes.

@ast

Adenosine receptor activation ameliorates type 1 diabetes.

@en

prefLabel

Adenosine receptor activation ameliorates type 1 diabetes.

@ast

Adenosine receptor activation ameliorates type 1 diabetes.

@en

P1433

Q36427003-2D962EF6-2403-4826-84DA-7C8043440EC7

P1476

Q36427003-8C392288-49C9-44DA-8649-D428C66AD4A8

P2093

Q36427003-3A170017-3870-4107-A236-39F1852A93E4

Q36427003-659BFAE2-6F3A-424A-B0EF-D0ED5DE13EA6

Q36427003-67D37AB5-4943-4080-B37A-D631A5341BFE

Q36427003-8C184C34-1ACA-4833-865D-BF1D0B11F7C6

Q36427003-98EEBD1D-8622-45AD-88C4-0C34352CAB1E

Q36427003-9B03A0C3-5468-4B6D-B8D7-6F6984CE7A46

Q36427003-BB360503-D6B2-4AD3-8FA4-DC96872F53F7

P2860

Q36427003-05D5E446-76D3-4157-9356-6BC5CB892DA3

Q36427003-0CC5EAC9-A981-4F71-8F4E-CA0F81DCB0D5

Q36427003-0D8C2D39-26ED-46C7-94A1-EC5707E977A1

Q36427003-15B3967C-48B6-4E8F-A708-109AC8A326B9

Q36427003-2445A23F-3C49-4322-A799-EC6AAE9DFBE4

Q36427003-3B857198-3143-4CAF-A576-E8C683BDC3F1

Q36427003-3E2B924D-5E4F-4CB1-A191-7118C98D26D7

Q36427003-45ECFB60-E2AB-479F-88C5-5514A2E17D35

Q36427003-4ECB1401-3F9C-47FE-B14B-A9CE347AE93F

Q36427003-52303A2E-6A56-4690-BF69-583DB95EFE4C

P304

Q36427003-041F4ACF-9A64-44FE-A01F-845F7AD97540

P31

Q36427003-6ECCDC3C-28F7-474C-BEDD-AC07FBF026A4

P356

Q36427003-B8DE2108-7395-46DA-B333-56E5994C803B

P407

Q36427003-B8A07B54-783B-47EA-8E1E-A890FBD4B065

P433

Q36427003-E3944376-F7F3-4904-90E7-4EBACD32E85F

P478

Q36427003-6C4A39EF-B2C9-443D-8D34-A311A6DA41AF

P50

Q36427003-467ECC9B-6A40-4D16-98E0-88783D7E71EA

Q36427003-92752D5D-6197-4C12-BC96-B177993BB303

Q36427003-A6009A28-0ED9-4914-81EE-26BC002DCD0D

Q36427003-FC844765-3814-4D3F-B9DB-9FF2A8CF8E21

P577

Q36427003-CFE5C2C7-723E-42C5-ACDD-156EA36F4534

P5875

Q36427003-622F9880-1EF8-48FD-BF59-DE6C5DF1CAF4

P698

Q36427003-E2D53801-CD27-4DD1-BC67-8603FAB94F08

P921

Q36427003-C9BB6F01-0417-448B-8C62-5CE0244F37C8

P932

Q36427003-EAA00811-16AF-4CE3-959E-74468DD2331B

P356

P1433

P1476

Adenosine receptor activation ameliorates type 1 diabetes

@en

P2093

Csaba Szabó

http://www.w3.org/2001/XMLSchema#string

David Bleich

http://www.w3.org/2001/XMLSchema#string

E Sylvester Vizi

http://www.w3.org/2001/XMLSchema#string

György Haskó

http://www.w3.org/2001/XMLSchema#string

Jon G Mabley

http://www.w3.org/2001/XMLSchema#string

Leonóra Himer

http://www.w3.org/2001/XMLSchema#string

Zoltán H Németh

http://www.w3.org/2001/XMLSchema#string

P2860

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

Receptors for purines and pyrimidines

Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.

Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease.

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

P304

2379-2388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.07-8213COM

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Bruce N Cronstein

Edwin A. Deitch

P577

2007-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6415804

http://www.w3.org/2001/XMLSchema#string

P698

17405852

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

2225539

http://www.w3.org/2001/XMLSchema#string